Introduction
Lung function declines with age (1) . This decline frequently manifests as progressive, irreversible organ failure notably in two recognized clinical settings: emphysema and idiopathic pulmonary fibrosis (IPF). These disorders represent major burdens of disability and mortality world-wide, and currently no therapies short of lung transplant are known to significantly change their natural history. While sometimes considered distinct, emphysema and IPF frequently co-exist(2, 3), suggesting they may have a shared etiology and pathobiology. In addition to age, cigarette smoke (CS) exposure is known to accelerate the onset of both emphysema and IPF (4, 5) . In some patients, even long after CS cessation, there is often a progressive decline in lung function (6) , suggesting that agerelated factors may cooperate with sustained CS-induced lung damage to cause these disorders. Understanding the biology underlying the susceptibility to these fatal disorders holds promise for rational prevention and therapy strategies that can improve outcome.
Telomeres are DNA-protein structures that protect chromosome ends from degradation.
Telomeres shorten progressively with cell division and critically short telomeres signal a DNA damage response that can lead to apoptosis (7) (8) (9) . Short telomeres are also a potent inducer of senescence, a permanent state of impaired cell cycle progression associated with accumulation of cyclin-dependent kinase inhibitors (7, 10) . Telomerase is a specialized polymerase that synthesizes telomere repeats (11, 12) . Telomerase has two essential components: a catalytic reverse transcriptase, TERT, which copies from a template within the RNA component, TR, to add new telomere sequence onto (13) (14) (15) (16) . In both humans and mice, telomerase deficiency and short telomeres cause a stem cell failure syndrome which manifests as a loss of regenerative capacity in tissues of rapid turnover: the skin, mucosa and bone marrow (reviewed in (17) ). Recent studies in families with IPF have indicated that telomerase mutations play a critical role in the genetics of lung disease (18, 19) . In fact, inherited mutations in the essential telomerase components hTERT and hTR are the most commonly identifiable defect in pulmonary fibrosis families, accounting for 10-15% of all cases (17) . Short telomeres are also a risk factor for idiopathic pulmonary fibrosis (20) . A recent study additionally noted shorter telomeres in the lungs of individuals with emphysema when compared with unaffected individuals with comparable CS exposure (21) . However, the role of short telomeres as a determinant of CS-induced lung disease in a genetically defined animal model has not been examined.
To approach this question, we studied telomerase deficient mice. In telomerase null mice, degenerative phenotypes are seen only when telomeres are short, which has established telomere length, and not telomerase loss itself, as the relevant genetic defect (22) (23) (24) (25) . Two mouse strains have shed light on the role of telomere length in disease. On the C57BL/6 strain of Mus musculus, mice have long heterogeneous telomere lengths (~50kb) and short telomeres can only be generated after several generations of breeding of telomerase RNA null, mTR -/-, mice (23) . The CAST/EiJ strain has shorter telomere lengths comparable to humans (~15kb), and telomerase null mice on this strain develop more severe phenotypes (24, 26) . In both genetic backgrounds, short telomeres have been noted to cause epithelial defects manifesting clinically as impaired wound healing in the skin, and mucosal atrophy in the intestinal tract (22, 24) . However, it is not known whether short telomeres affect the homeostasis of alveolar epithelium, a putative site of injury in emphysema and IPF. Here we show that although mice with short telomeres have no baseline histologic defects, they are more susceptible to developing emphysema after CS exposure. The emphysema susceptibility defect is intrinsic to the lung parenchyma, and CS causes additive DNA damage to telomere dysfunction thus impairing epithelial recovery. We also report young-onset emphysema cases in telomerase mutation carriers with CS exposure history. Our data identify short telomere length as a genetic determinant of emphysema susceptibility and of CS-induced lung disease.
Methods
Mice. Mice were housed at the Johns Hopkins University School of Medicine campus, and all procedures were approved by its Institutional Animal Care and Use Committee.
CAST/EiJ mTR +/-mice with short telomeres were generated by interbreeding heterozygous mice for 8-10 generations as described (24 thermocycler using iQ SYBR Green Supermix (BioRad, Hercules, CA). The expression of each gene was normalized to HPRT and β 2 -microglobulin using the Bio-Rad software.
Primer sequences are listed in the Supplementary Table. Subjects. Subjects were evaluated at Johns Hopkins Hospital. The study was approved by the Johns Hopkins Medicine Institutional Review Board and participants gave written, informed consent. hTR was sequenced from genomic DNA, and lymphocyte telomere length was measured using flow-FISH (18) . hTR levels were measured in early passage lymphoblastoid cells from mutation carriers and non-carriers using qRT-PCR (29) .
Statistics. We used GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego CA). Means were compared using Student's t-test, and all P-values are two-sided.
Results

Mice with short telomeres do not have obvious de novo fibrosis or emphysema
To examine whether mice with short telomeres develop de novo disease, we first examined lung histology in adult CAST/EiJ (mTR +/-generation 8-10 mice) and C57BL/6J (mTR -/-fourth generation of breeding, hereafter known as G4) mice. We did Figure 1A ). These data indicated that adult mice with short telomeres, at least on the CAST/EiJ and C57BL/6J strains, do not develop spontaneous fibrosis or air space enlargement in the age groups we examined.
Mice with short telomeres are more susceptible to CS-induced lung disease
CS exposure is a risk factor in age-related lung disease, we therefore tested whether genetically determined short telomere length will predispose mice to develop lung disease after a chronic exposure. We randomized age-and gender-matched CAST/EiJ wildtype and short telomere mice to either filtered air or CS in an automated chamber for 6 months; however neither group developed weight loss or morphometry defects indicating this is a resistant strain(30), even when telomeres are short (not shown). We similarly randomized age-and gender-matched C57BL/6J wildtype and G4 mice.
C57BL/6J mice are known to be modestly susceptible to CS (30) , and indeed both wildtype and G4 mice had decreases in body weight confirming their susceptibility ( Figure 1C and Supplementary Figure 3A ).
We then examined whether short telomeres determined the severity of CSinduced injury assessed by lung morphometry and lung function studies. Wildtype C57BL/6J mice developed no significant air space disease compared to air-exposed (27) . In contrast, G4 mice had a significantly larger MLI than air-exposed controls, indicating emphysematous air space changes ( Figure 1A -1B). The emphysematous changes were regional in G4 mice with focal areas more prominently affected ( Figure 1A ). The increased MLI was paralleled by alterations in pulmonary function with G4 mice having the largest ratio of RV to TLC, a physiologic measure of emphysema ( Figure 1C and Supplementary Figure 3B ). Lung mechanics further showed that, in contrast to air-exposed controls, G4 mice had significant decreases in the percentage of TLC at a fixed pressure (V 10 ), indicative of altered functional residual capacity. G4 mice exposed to CS also had decreased lung volume-adjusted compliance ( Figure 1C and Supplementary Figures 3C-3D ). Similar compliance defects have been reported in CS-exposed murine models (31, 32) . Since humans develop increased compliance in the setting of emphysema, the trends we report, along with others' previously, may represent differences in the consequences of emphysema on lung mechanics in rodents especially because we found no evidence of increased collagen deposition or synthesis in G4 mice after CS exposure by both
Masson's trichrome staining as well as active collagen expression (Supplementary Figure   2 ). These morphometric and lung function studies indicated that short telomeres are a determinant of CS susceptibility in murine emphysema.
The telomere-mediated CS susceptibility is independent of circulating cell genotype CS induces an exuberant inflammatory response in the lung, and inflammation is considered a critical determinant of emphysema pathogenesis (6) . Compared with air-F o r R e v i e w O n l y 11 exposed controls, CS-exposed mice had significantly higher levels of alveolar macrophages ( Figure 2A-2B ), as has been seen in other studies (27) . However, when we compared the two groups of CS-exposed mice, we did not identify statistically significant differences in the number of alveolar macrophages even after correcting for the MLI ( Figure 2B and Supplementary Figure 4A ).
The observation that G4 mice were more susceptible to CS suggested that the emphysema observed in G4 mice may be due to a telomere defect in either the inflammatory cells themselves or resident lung cells. To distinguish these possibilities,
we performed an adoptive transfer anticipating that if the susceptibility were derived from circulating cells, wildtype bone marrow would rescue the CS susceptibility in G4 mice. Similarly, wildtype mice that receive bone marrow from G4 donors would acquire the susceptibility. To control for the effects of radiation, we transplanted wildtype mice with wildtype bone marrow, and G4 mice with G4 bone marrow. By day 28 after lethal irradiation, in contrast to uninjected mice, all the transplanted mice survived indicating successful donor engraftment. Mice were then exposed to CS for 6 months, and at the end of the exposure, we confirmed successful donor engraftment (Supplementary Figure   4B ). In wildtype recipients that received bone marrow from either a wildtype or G4
donor, there was no evidence of CS-induced emphysema as evidenced by the unchanged MLI, similar to data in untransplanted mice ( Figure 2E and Figure 1A -1B). In contrast, G4 mice showed significant increases in MLI regardless of whether they received wildtype or G4 marrow ( Figure 2E ). Importantly, when we quantified the inflammatory response, we found that CS-exposed recipient mice, both wildtype and G4, had similar macrophage recruitment in our model was independent of telomere length. These data indicated that the telomere-mediated CS susceptibility did not depend on the genotype of circulating cells, but was likely intrinsic to resident lung cells.
CS causes additive DNA damage to short telomeres in lung epithelium
Because our data indicated that short telomeres in resident lung cells likely determine the emphysema susceptibility, we focused on defining how telomere length affects epithelial homeostasis after CS, a key event in the pathogenesis of the air space enlargement which characterizes this disease (6) . We quantified DNA damage by examining DNA double strand breaks detected by 53BP1 foci specifically in lung epithelial cells. The 53BP1 protein binds to DNA at the site of double strand breaks, and we found that at baseline the percentage of damaged terminal bronchiole epithelial cells was five-fold higher in G4 mice ( Figure 3A -3B), consistent with their known dysfunctional telomeres that bind 53BP1 (9, 23, 33) . In mice that were exposed to CS, there was additive damage with G4 mice accumulating the greatest burden of cells with double strand DNA breaks ( Figure   3B ). Owing to technical difficulties, we could not specifically stain for 53BP1 foci in type 2 alveolar epithelial cells (AECs), but adjacent Clara epithelium likely reflects damage patterns in these adjacent cells similarly exposed to CS. We next examined whether CS may have caused an acquired state of telomere shortening by measuring telomere length by quantitative FISH in AECs (20) . We detected fewer telomere signals in G4 mice compared with wildtypes as predicted; however, we could not detect mice have long heterogeneous telomeres making it difficult to detect subtle differences in mean telomere length (23) , this highly sensitive FISH-based assay does not entirely exclude the possibility of minor telomere shortening after a 6 month CS exposure. To assess whether other forms of damage such as oxidative stress may be increased in the susceptible group, we examined nitrotyrosine and 8-hydroxy-2-deoxyoguanosine immunohistochemistry, but did not detect differences between wildtype and G4 CSexposed mice (not shown). Together, these data indicate that the short telomeres, as genetically determined in G4 mice, and the environmentally acquired CS-induced DNA damage, are additive.
Short telomeres limit epithelial recovery after CS
To determine the cellular consequences of CS-induced damage and short telomeres, we examined evidence of apoptosis. The baseline apoptosis rate was very low and G4 mice did not exhibit a significant increase in TUNEL positive cells relative to wildtype controls (Supplementary Figure 4C) . Although there was an increase in both groups with CS, this difference was not statistically significant (Supplementary Figure 4C) . Thus short telomeres do not appear to contribute significantly to elevated apoptosis after 6 months of CS at the single time point we examined.
Since short telomeres are a potent inducer of cellular senescence, we next examined epithelial proliferation in vivo during and after CS. Because the proliferative rate of AECs is slow at any given time, we studied the dynamics of epithelial During a 14 day CS exposure, the proliferation of type 2 AECs dropped similarly in wildtype and G4 mice ( Figure 4A ). However, when we quantified the proliferative AEC fraction after a 14 day recovery period, it significantly lagged in G4 mice ( Figure 4A ).
We also found similar defective proliferation of terminal bronchiole Clara cells during the recovery period ( Figure 4B ). These data indicate that epithelial proliferation is dynamic during and after CS exposure, and that short telomeres limit the proliferative recovery of epithelial cells after CS injury.
Failure to downregulate p21 in short telomere lungs after CS
The fact that short telomeres impair the recovery of epithelial cells after CS suggested that some cells may show hallmarks of senescence. Because senescence due to telomere shortening has been associated with accumulation of specific cyclin-dependent kinase inhibitors(34-36), we measured their expression in whole lung lysates by real time PCR.
We compared levels in two different experiments. First, in a long-term experiment, we examined air-and CS-exposed mice at baseline, at the end of a 6 month CS exposure, and during the recovery period, one week later. In a short-term experiment, we measured levels at baseline, immediately after a 14 day CS exposure, and during recovery 14 days later. INK4a levels were higher in G4 lungs from older mice ( Figure 5D ), as seen previously (35) . Nonetheless, levels of all three of these cyclin-dependent kinase inhibitors were not affected by CS immediately or during the recovery periods in both the short-and long-term experiments ( Figure 4C ,D,F,G,H,J). However, in both experiments, p21 expression levels were dynamic, increasing modestly after CS as seen previously (37) . Remarkably, p21 levels fell precipitously during the recovery levels dropping up to 15-fold in wildtype lungs during the proliferative recovery ( Figure 4E and 4I). Importantly, p21 levels failed to downregulate in G4 lungs at the recovery time point in both experiments with up to 6-fold higher levels relative to control lungs ( Figure 4E and 4I). These data which paralleled the defects in epithelial proliferation in G4 mice indicated that p21 may contribute to the telomere-mediated proliferative lag we observed in the recovery period ( Figure 4A-4B ).
To investigate whether p21 plays a role in epithelial cell cycle progression, we examined alveolar cells and found that the p21 protein was detectable in wildtype luminal alveolar cells by immunofluorescence (Supplementary Figure 4D) . We next examined the cell cycle progression of pulmonary epithelium in p21 knockout mice by examining EdU incorporation. We found that p21 -/-animals had strikingly a two-fold increase in the fraction of proliferating AECs as well as Clara cells lining terminal bronchioles ( Figure   5A -5F). Importantly, there was no concurrent increase in the basal proliferation rate of intestinal villous epithelium indicating that p21 may specifically regulate the cell cycle 
Young-onset emphysema in telomerase mutation carriers
Telomerase mutations are a risk factor for IPF, but heterogeneous pulmonary disease phenotypes have been seen in telomerase mutation carriers (18, 38, 39) . We sought to determine whether telomerase mutations and short telomeres are susceptibility factors in human CS-induced emphysema. We identified a family with a combined emphysemafibrosis spectrum of lung disease. The proband was a 55 year old female was diagnosed with emphysema at the age of 44 after a 29 pack-year smoking history ( Figure 6A-6C ).
The family history was notable for her father who died from IPF at the age of 70, and a niece with bone marrow failure ( Figure 6A ). Her sister was diagnosed at the age of 34 with a combined emphysema and pulmonary fibrosis syndrome after a 15 pack-year smoking history and subsequently died at age 46 from end-stage lung disease ( Figure 6A and 6D-6E). Both the proband and her sister had normal alpha-1 antitrypsin levels. In light of the family history suggestive of a telomerase defect(40), we sequenced the telomerase genes, and identified a novel heterozygous mutation hTR del375-377 within the essential Box H motif which is critical for the biogenesis and stability of hTR (41, 42) .
The hTR mutation segregated with the pulmonary disease in affected family members, and quantification of hTR levels in cells from mutation carriers showed they had approximately 50% of the levels of their first degree non-carrier relatives, consistent with a haploinsufficiency mechanism of telomerase deficiency ( Figure 6H ). Mutation carriers Figure 6I ). The observations in this family indicated that inherited mutations in telomerase might be risk factors for young-onset emphysema, alone or in combination with pulmonary fibrosis, in individuals with a smoking history.
Discussion
We sought to understand the mechanisms by which short telomeres might contribute to lung disease in humans by studying telomerase null mice. We identified telomere length and telomerase deficiency as a susceptibility factor in emphysema. Late generation telomerase null mice developed emphysematous air space enlargement after a chronic CS exposure as evidenced by morphometric differences which affected lung function.
Telomere length is heterogeneous and heritable across populations, and short telomeres accumulate with age. Our data indicate that short telomere length is a genetic determinant of emphysema in mice, and may contribute to the susceptibility to CSinduced lung disease with age in humans.
Several pieces of evidence point to epithelial injury being a primary mechanism of the telomere associated CS-induced susceptibility. First, we show that the telomereassociated emphysema susceptibility does not depend on a telomere defect in bone marrow-derived cells. In adoptive transfer, short telomeres caused emphysema susceptibility independent of inflammatory cell genotype indicating that although the inflammatory response after CS is striking, its presence is not sufficient to induce emphysema in our model. Our adoptive transfer experiments also suggest that the number of macrophages recruited is not a determinant of the CS-induced emphysema as both wildtype and short telomere mice had similar recruitment. In addition, we show that in epithelial cells, DNA damage due to CS is additive to telomere dysfunction with short telomere mice carrying the greatest burden. Because of the slow turnover rate of lung epithelium, we developed an assay to track epithelial-specific proliferation in vivo and show that it is dynamic during and after CS exposure. In parallel to the dynamics of epithelial proliferation, p21 levels are significantly down-regulated during the recovery phase (increased proliferation), and in short telomere mice there is a failure of this downregulation. In situ studies have also found p21 upregulation in humans lungs with emphysema (21) . These data suggest that p21 is a candidate for mediating the senescence-like phenotype we observe and associated emphysema susceptibility.
Choudhury et al have shown that p21 loss rescues telomere degenerative defects in the bone marrow (43) . This study, together with our data showing p21 is a critical regulator of alveolar epithelial proliferation, point to p21 as a candidate effector of the telomeremediated susceptibility. Future studies in compound p21 knockout mice with short telomeres can definitively establish whether rescue of the telomere-mediated emphysema susceptibility by p21 deletion is feasible and are ongoing. Although attempts to reverse the telomere-mediated senescence after CS may be possible in mice, this strategy may concurrently increase the risk of malignant transformation. p21 is a known tumor suppressor in lung cancer and p21 -/-mice have a known increased incidence of How might epithelial proliferative defects lead to alveolar breakdown? Our data suggest at least two possibilities: First, it is possible that the defective type 2 AEC proliferation in short telomere mice directly leads to regenerative failure and remodeling of the lung. We identified the proliferative defects up to 14 days after CS exposure so in the setting of repetitive injury cycles as occurs with CS, it may be that defects become irreversible and directly lead to regional alveolar loss. Chronic low grade apoptosis due to the combined effect of CS-induced and telomere damage may also contribute to alveolar loss. Another possibility is that the combined telomere and non-telomere DNA damage induces epithelial senescence and this indirectly contributes to alveolar destruction. Senescence is a complex process associated with gene expression changes and a cytokine and protease secretory phenotype in vitro (45) . A recent study showed that senescent alveolar cells are associated with a higher pro-inflammatory cytokine profile in vitro (46) . While our data do not entirely exclude other lung parenchymal cell types or extra-pulmonary factors such as nutritional deficiency as contributing to the telomere-mediated emphysema, the findings we show support a model where lung-epithelial dysfunction contributes to the emphysema phenotype in vivo. We did not identify de novo pulmonary fibrosis or emphysema in the mice with short telomeres in the age groups we examined. The absence of a phenotype within the relatively short lifespan of mice is consistent with the finding that in individuals who inherit telomerase mutations, disease onset is rare before the age of 40 (18, 19, 29, 39, 47 ). Emphysema onset is also age-dependent and is rare prior to the sixth decade(3, 6).
Thus although short telomere length alone does not cause disease phenotypes, the combined telomere and CS-induced damage together overcomes a threshold and manifests as emphysema. The clinical observations, along with findings in our model indicate that even though the short telomere defect alone is not sufficient to induce lung disease in mice, it serves as a first genetic hit in a likely multi-step process that is cumulative with age, and accelerated with CS.
Our data in mice implicate a role for telomere length in emphysema pathogenesis, and not only in idiopathic interstitial lung disease. Emphysema and pulmonary fibrosis have traditionally been considered distinct clinical entities; however in recent years it has become clear that as many as twenty percent of emphysema patients have concurrent interstitial lung disease(2, 3). Here we show that within a single family, the pulmonary manifestations of telomerase insufficiency are heterogeneous and can include emphysema, IPF as well as the combined syndrome. In a cohort of telomerase mutation carriers, 5% of cases were reported to have a history of spontaneous pneumothrax or had the diagnosis of chronic obstructive pulmonary disease (39) . It may therefore be that emphysema alone, or combined with pulmonary fibrosis, are rare manifestations of inherited telomerase mutations. Identifying the factors that determine whether the first presentation in telomerase mutation carriers is primarily emphysema, IPF, or both will be important to examine in larger studies. Given the early onset of disease in the patients we describe, consideration of telomerase genetic testing may be indicated in young-onset emphysema patients with a personal or family history suspicious for telomere-mediated disease (17, 40) .
In summary, we report that short telomere length is a susceptibility factor for CS-induced emphysema in mice. Our data together identify a novel genetic mechanism of emphysema susceptibility, and suggest that short telomeres may contribute to the differential susceptibility to CS across populations, and with aging. Representative H&E images show air space enlargement in G4 mice compared with controls after 6 month exposure. RA refers to room air. Images were obtained at 100X final magnification. The emphysematous changes shown in the lower right panel represent regional areas of emphysema that were seen in short telomeres CS-exposed mice. B. Mean linear intercept (MLI) quantification in a blinded analysis from 12-15 mice/group. Mice were 9-11 months of age, and were gender-matched across groups. C. Table shows mean values of body weight and pulmonary function studies. RV/TLC refers to the ratio of the residual volume relative to the total lung capacity (n=7-9 mice/group). V 10 refers to the percentage of the total lung capacity (TLC) at 10 cm H 2 0. Specific compliance refers to compliance corrected for TLC. Error bars represent s.e.m. * and ** refer to P-values <0.05 and <0.01, respectively. P-values in (C) refer to comparisons with mean in respective RA-exposed control group. delivered EdU subcutaneously for 14 days, and proliferation in type 2 alveolar cells was identified by co-staining with cytoplasmic SPC (n=5 mice per group, 6-8 high power fields/mouse). B. Proliferation of terminal bronchiolar Clara cells was measured similar to (A), but with EdU co-localization with CC10 (n=5 mice/group, 5-10 terminal bronchioles/mouse). C-F. Relative expression levels of cyclin dependent kinase inhibitors from 3 groups of mice are shown from a long-term experiment: room air exposed mice represent baseline time point, mice exposed to 6 month of CS, and mice that were exposed to 6 months of CS that were then allowed to recover in RA for 7 days (n=5-8 mice for each data point, 9-11 months old). G-J. Relative expression levels of cyclin dependent kinase inhibitors from 3 groups of mice are shown from a short-term experiment: room air exposed mice represent baseline time point, mice exposed to 14 day CS exposure, and mice that were exposed to 14 day CS that were then allowed to recover in RA for 14 days (n=5 mice for each data point, 6 months old). Expression in whole lung lysates was measured by real-time PCR and normalized to Hprt and β 2 m expression. WT RA control group transcript levels were assigned a value of 1.0 for relative comparison. Error bars represent s.e.m. * and ** refers to P-values <0.05 and <0.01, respectively. -/-mice, respectively. I. Bar graph shows quantitation after twice daily injections for 2 days. n=5 mice/group, age 3-4 months, 10 HPF were analyzed/mouse. Error bars represent s.e.m. * refers to P-value <0.05. Figure 6 . Early onset emphysema as a manifestation of inherited telomerase mutation. A. Pedigree with features of telomere syndrome including idiopathic pulmonary fibrosis, bone marrow failure and premature hair graying shows autosomal dominant inheritance. The proband is indicated by an arrow and the shaded squares/circles indicate mutation carrier. The proband's father is a probable carrier, and the sister is an obligate carrier. The summary of the clinical history is listed below with CS referring to the cigarette smoking history. B&C. Apical and mid-lung computed tomography (CT) images from the proband show evidence of emphysema with apical bullae and hyperinflation. D&E. CT images of the proband's affected sister show subcutaneous emphysema due to a spontaneous pneumothorax, apical bullae as well as mid-lung ground glass infiltrates with septal thickening consistent with a combined emphysema and interstitial lung disease phenotype. 28 affected mutation carriers (n=3), and DKC1 mutation carriers (n=2). Data were generated by quantitative real-time PCR and hTR levels were normalized to ARF3 levels. ** refers to P-value <0.01. I. Lymphocyte telomere length in proband and mutation carriers shows significant shortening relative to age-matched controls. Identifiers refer to pedigree in Figure 6A . 
